About

[ Chapter 1. -REGENOVA- ] [REGENOVA BIO] was a global biotechnology corporation. Its primary research fields were cell therapy and tissue regeneration, with regenerative medicine—the science of restoring damaged bodies—as its core business. Regenova's corporate goal was simple. "Eliminating irreparable wounds." Their ultimate objective was to treat conditions that conventional medicine struggled to fully recover, such as severe burns, internal damage, nerve injuries, and tissue destruction from accidents. To achieve this, Regenova launched a massive research project. [Chapter 2. - 🧬REGENOVA — -REGEN PROJECT- ] The [REGEN PROJECT] began. The goal was to artificially maximize the human body's natural regenerative capacity. When human cells are damaged, they create new cells to repair the tissue. However, this ability had its limits. Regenova's researchers developed artificial regenerative cells to transcend these limits. [ Chapter 3. -🧬REGENOVA —RGC-01- ] [Regenerative Cell - 01] RGC-01 is an artificial cell designed to seek out damaged tissue and stimulate the regeneration of surrounding cells once injected into the human body. The intended mechanism was simple: Detect Damage → Stimulate Regeneration → Repair Tissue → Terminate Activity The final goal was to ensure RGC-01's activity naturally ceased once the damage was repaired. However, when RGC-01 was first created, this final stage was incomplete. RGC-01 lacked the ability to judge when to stop regenerating. The researchers proceeded with experiments, leaving the resolution of this issue as the final phase of the project. [ Chapter 4. -Regenerative Cell- ] In early experiments, RGC-01 showed remarkable results. The recovery speed of damaged tissue was incomparably faster than existing treatments. Even severe tissue damage was repaired quickly, and regeneration was observed in tissues previously deemed impossible to recover. The results regarding **nerve damage** were particularly decisive. In some experiments, the function of damaged nerve tissue was even restored. Regenova judged that if RGC-01 succeeded, it could change the history of medicine. Clinical application feasibility began to be reviewed rapidly, and the company started pushing the REGEN PROJECT as its next-generation core business. However, as long-term observation began, anomalies were discovered. ㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡㅡ While Regenova was hiding these facts, a wastewater leak at the laboratory released RGC-01 into the external environment. The contaminated wastewater flowed through nearby streams into the water supply. RGC-01, which could not be removed by existing purification systems, entered the bodies of citizens through tap water and domestic use. Initially, no one noticed anything wrong, but over time, infected individuals began to appear, eventually leading to a massive mass infection event. [ 🧬 Detailed information regarding REGENOVA — REGEN PROJECT is recorded in the Lorebook. ]